
ePRISM® can help improve patient satisfaction. Its award–nominated informed consent document facilitates physician/patient interaction and dialogue. Written at the eighth–grade level for improved understanding, the document can be customized to fit a hospital’s legal/medical requirements and translated into the patient’s language. With its embedded risk profiles, the consent form can also function as a clinician’s tool to facilitate evidence–based discussion of treatment options, making patients feel more in control and a part of their care and treatment decisions.
By identifying and applying the optional level of care using ePRISM®, caregivers can reduce the overall cost of care for a specific patient by:
HOS solutions also help justify, as well as optimize a hospital's financial performance, protecting against recovery by RAC audits and denials:
By transforming evidence gathered for a population into an individualized decision–making tool for clinicians and their patients, ePRISM® can lead to:


Click the title to read full article.
American Heart Association Late-Breaking Clinical Trial Report New Predictive Modeling Tool Helps Identify High-Risk PCI Patients at Point of Care New Product Announcement ePRISM® and Saint Luke’s Hospital, Kansas City nominated as finalist for ClearMark Award HOS and ACC form Strategic Partnership HOS Announces New President & Chief Sales & Marketing Officer HOS Announces New CEO PRESS - A New Consent Form PRESS - Heart Stents PRESS - Risks More Clear Through New Consent Form PRESS - Calculating risks of cardiac treatments PRESS - Amerinet Puts HOS on Contracted Supplier List